Adenosine A2B Receptor: A Pathogenic Factor and a Therapeutic Target for Sensorineural Hearing Loss

    December 2020 in “ The FASEB Journal
    Jeanne M. Manalo, Hong Liu, Dalian Ding, John Hicks, Hong Sun, Richard Salvi, Rodney E. Kellems, Fred A. Pereira, Yang Xia
    New to Adenosine? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary Blocking adenosine A2B receptor may prevent or treat hearing loss.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →